One continuity risk worth flagging: Invigor Medical discontinued GLP-1s, and Hims cancelled its compounded semaglutide pill under FDA and Novo Nordisk pressure (Novo has filed 130-plus lawsuits across 40 states)
By partnering with us, youll gain access to cutting-edge protocols, ongoing education, and a supportive community of like-minded professionals
Eli Lilly announced positive Phase 3 results for retatrutide, a first-in-class triple agonist targeting GLP-1, GIP, and glucagon receptors
You cant just stop taking it the day you decide to try for a babyyou need to give your body time to completely clear the medication before conception
GLP-1 receptor agonists offer dual benefits by improving insulin secretion and suppressing glucagon release in a glucose-dependent manner
Hypoglycemia : Monitor for symptoms of hypoglycemia and report any difficulties with glycemic control